encorafenib,binimetinib
pfizer
['bimeti', 'cobra', 'encorafenib', 'nsclc', 'sclc']
very nice efficacy of encorafenib + bimetinib in braf nsclc presented by . this combo is currently tested in the #encobraf study sponsored by , available . #asco23 very promising combination. 
Head of pulmonology unit @pneumo_LS @CHUdeLyon
Professor of Pulmonology @UnivLyon1
Scientific head @URCOT_lyon & @IFCTlung
Lung cancer screening addict.